|
N.V. Pizova
MODERN APPROACHES TO THE PHARMACOTHERAPY OF PARKINSON'S DISEASE: THERAPY OF MOTOR SYMPTOMS - HYPOKINESIA, RIGIDITY AND TREMOR
|
8-11 |
|
O.S. Levin (1, 2), E.A. Lyashenko (1, 2)
SLEEP DISORDERS IN PARKINSON'S DISEASE
|
12-18 |
|
V.V. Yastrebova, D.V. Yastrebov
CLINICAL MANIFESTATION AND PHARMACOLOGICAL TREATMENT OF BIPOLAR AFFECTIVE DISORDER
|
20-30 |
|
L.V. Romasenko (1), V.M. Makhov (2)
SYNDROME OF FUNCTIONAL DYSPEPSIA AND COMORBID MENTAL DISORDERS
|
32-35 |
|
A.G. Merkin (1, 2), A.N. Komarov (2), E.N. Dinov (3), O.V. Beloskurskaya (3), A.S. Bychkova (1), L.P. Kezina (2), I.A. Nikiforov (1)
ASTHENIC AND DEPRESSIVE DISORDERS IN ELDERLY PATIENTS IN OUTPATIENT PRACTICE (DIFFERENTIAL DIAGNOSIS AND THERAPY)
|
36-40 |
|
N.V. Fedorova
FACTORS INFLUENCING ADHERENCE TO THE TREATMENT IN PARKINSON'S DISEASE
|
41-44 |
|
L.S. Kanaeva
PREDICTIVE ROLE OF CLINICAL AND SOCIAL FACTORS IN EVALUATION OF EFFICACY OF PHARMACOTHERAPY IN PATIENTS WITH NON-PSYCHOTIC DEPRESSION
|
45-52 |
|
M.Yu. Drobizhev (1), A.V. Fedotova (2), S.V. Kikta (3)
MASKED DEPRESSION IN NEUROLOGICAL PRACTICE. ATTEMPT TO IMPARTIAL ANALYSIS
|
53-57 |
|
E.A. Katunina, N.V.Titova
LEVODOPA-INDUCED DYSKINESIAS IN PARKINSON'S DISEASE: PATHOGENESIS, CLINICAL MANIFESTATION, AND APPROACHES TO THE TREATMENT
|
58-69 |
|
G.M. Rumyantseva
PROSPECTS FOR THE USE OF DRUG CEREBRUM COMPOSITUM N IN THE THERAPY OF MENTAL ILLNESS (ANALYTIC REVIEW)
|
70-73 |
|
A.M. Etingof, A.N.Magomedova
THE USE OF OLANZAPINE, GENERAL AND PRACTICAL ASPECTS
|
74-79 |
Русский
